Search results
People also ask
What is an International Nonproprietary Name (INN)?
What is the International Nonproprietary Name (INN) expert group?
What is a nonproprietary name?
What is the International Nonproprietary Names programme?
International Nonproprietary Names (INN) for biological and biotechnological substances (a review) 2022. 11 December 2023. | Publication. Download (1.2 MB)
More than 50 years ago, WHO established the International Nonproprietary Name (INN) Expert Group/WHO Expert Committee on Specifications for Pharmaceutical Preparations, to assign nonproprietary names to medicinal substances, so that each substance would be recognized globally by a unique name. These INNs do not give proprietary rights, unlike a
Jan 3, 2022 · Abstract. International Nonproprietary Names (INN) are assigned by the World Health Organization (WHO) to pharmaceutical substances to ensure global recognition by a unique name. INN facilitate safe prescribing through naming consistency, efficient communication and exchange of information, transnational access and pharmacovigilance of ...
- James S. Robertson, Ursula Loizides, Akinola Adisa, Ana López de la Rica Manjavacas, Vicente Rodilla...
- 2021
assign nonproprietary names to medicinal substances, so that each substance would be recognized globally by a unique name. These INNs do not give proprietary rights, unlike a trade mark, and can be used freely as they are public property. INNs have been assigned to biological products since the early days of the INN Programme.
International Nonproprietary Names (INN) facilitate the identification of pharmaceutical substances or active pharmaceutical ingredients. Each INN is a unique name that is globally recognized and is public property. A nonproprietary name is also known as a generic name. General guidance. Mandate.
Dec 31, 2018 · International Nonproprietary Names (INN) for biological and biotechnological substances (a review) 2019. 31 December 2018. | Publication.
products". The International Nonproprietary Names (INN) Programme is a core activity embedded in the normative functions of WHO and has served the global public health and medicines community for over sixty years. The Programme was established to assign nonproprietary names to pharmaceutical substances so that each substance would be